RICCI, R.P., G.L. BOTTO, J.M. BENEZET, J.C. NIELSEN, L. DE ROY, O. PIOT, A. QUESADA, R. QUAGLIONE, D. VACCARI, L. MANGONI, A. GRAMMATICO and Milan KOZÁK. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study. Heart Rhythm. USA: Elsevier Science, 2015, vol. 12, No 11, p. 2239-2246. ISSN 1547-5271. Available from: https://dx.doi.org/10.1016/j.hrthm.2015.06.041.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study
Authors RICCI, R.P. (380 Italy), G.L. BOTTO (380 Italy), J.M. BENEZET (724 Spain), J.C. NIELSEN (208 Denmark), L. DE ROY (56 Belgium), O. PIOT (250 France), A. QUESADA (724 Spain), R. QUAGLIONE (380 Italy), D. VACCARI (380 Italy), L. MANGONI (380 Italy), A. GRAMMATICO (380 Italy) and Milan KOZÁK (203 Czech Republic, belonging to the institution).
Edition Heart Rhythm, USA, Elsevier Science, 2015, 1547-5271.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.391
RIV identification code RIV/00216224:14110/15:00086546
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.hrthm.2015.06.041
UT WoS 000366112600009
Keywords in English Cardiac pacing; Managed ventricular pacing; Randomized controlled trial; Atrial fibrillation; PR interval
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 11/2/2016 14:19.
Abstract
BACKGROUND Pacing in the right ventricle can cause a variety of detrimental effects, including atrial tachyarrhythmias (atrial tachycardia [AT]/atrial fibrillation [AF]). OBJECTIVE The purpose of this study was to evaluate the incidence and predictors of persistent AT/AF in patients with long-term exposure to ventricular pacing. METHODS In a multicenter international trial, 605 patients (age 75 +/- 11 years, 240 women) referred for replacement of an implanted pacemaker or implantable cardioverter-defibrillator (ICD), with a history of high-percentage (>40%) ventricular pacing, were randomly allocated to standard dual-chamber pacing or managed ventricular pacing (MVP), a pacing modality that minimizes ventricular pacing. The main end-point of this secondary analysis of the PreFER MVP randomized study was persistent AT/AF, defined as >= 7 consecutive days with AT/AF or AT/AF interrupted by atrial cardioversion or AT/AF present during 2 consecutive follow-up visits. RESULTS Persistent AT/AF was observed in 71 patients (11.7%) after 2 years of follow-up. At multivariable Cox regression analysis, prior AT/AF (hazard ratio [HR] 2.85, 95% confidence interval [CI] 1.20-6.22, P = .017) and ventricular pacing percentage, estimated in the first 3 months, >= 10% (HR 3.24, 95%95% CI 1.13-9.31, P = .029) were independent predictors for persistent AT/AF. MVP was associated with persistent AT/AF risk (HR 3.41, 95% 95% CI 1.10-10.6, P = .024) in the subgroup of patients with baseline long PR interval (PR >230 ms) but not in the whole population. CONCLUSION In pacemaker and ICD replacement patients, a high percentage of ventricular pacing is associated with higher risk of persistent AT/AF. Use of algorithms that minimize right ventricular pacing may benefit patients with normal spontaneous AV conduction but should be evaluated with caution in patients with long PR interval.
PrintDisplayed: 1/9/2024 08:46